Nottingham, United Kingdom

Karrar A Khan

This inventor holds 4 USPTO granted patents. Top assignee: The Boots Company Plc. Active years: 1989-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karrar A Khan. Retrieved from https://idiyas.com/inventor/karrar-a-khan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 84(Granted Patents)


Location History:

  • West Bridgford, GB (1989)
  • Nottingham, GB (1989 - 1996)

Company Filing History:


Years Active: 1989-1996

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Karrar A Khan: Innovator in Pharmaceutical Technology

Introduction

Karrar A Khan is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceutical technology, holding a total of four patents. His work focuses on the development of innovative solutions that enhance the efficacy and delivery of medications.

Latest Patents

Among his latest patents is a groundbreaking pharmaceutical tablet designed to improve patient compliance and therapeutic outcomes. This invention reflects his commitment to advancing healthcare through innovative drug delivery systems.

Career Highlights

Karrar A Khan is currently employed at The Boots Company Plc, a leading pharmacy-led health and beauty retailer. His role at the company allows him to leverage his expertise in pharmaceutical sciences to develop new products that meet the needs of consumers.

Collaborations

Throughout his career, Karrar has collaborated with esteemed colleagues such as Jeffrey Dickinson and Paul Bresloff. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of cutting-edge pharmaceutical solutions.

Conclusion

Karrar A Khan's contributions to the pharmaceutical industry exemplify the impact of innovation in healthcare. His dedication to improving drug delivery systems through his patents highlights the importance of research and collaboration in advancing medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…